MedPath

长春迪瑞制药有限公司

Ownership
-
Established
1998-08-04
Employees
-
Market Cap
-
Website
www.diruizhiyao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

133

NMPA:133

Drug Approvals

Zinc Sulfate and Allantoin Eye Drops

Product Name
硫酸锌尿囊素滴眼液
Approval Number
国药准字H20093792
Approval Date
Feb 5, 2024
NMPA

Fluconazole Eye Drops

Product Name
氟康唑滴眼液
Approval Number
国药准字H20093769
Approval Date
Feb 5, 2024
NMPA

Sodium Hyaluronate Eyes Drops

Product Name
玻璃酸钠滴眼液
Approval Number
国药准字H20233944
Approval Date
Jul 25, 2023
NMPA

Ribavirin Buccal Tablets

Product Name
利巴韦林含片
Approval Number
国药准字H22025424
Approval Date
Apr 13, 2021
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H22022118
Approval Date
Apr 13, 2021
NMPA

Raceanisodamine Eye Drops

Product Name
消旋山莨菪碱滴眼液
Approval Number
国药准字H20113036
Approval Date
Dec 22, 2020
NMPA

炎可宁片

Approval Number
国药准字Z22025050
Approval Date
Apr 27, 2020
NMPA

复方黄连素片

Approval Number
国药准字Z22025042
Approval Date
Apr 27, 2020
NMPA

维C银翘片

Approval Number
国药准字Z22026047
Approval Date
Apr 27, 2020
NMPA

心宁片

Approval Number
国药准字Z22025049
Approval Date
Apr 27, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 14
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.